ascopubs.org

Adjuvant Therapy in Patients With Resected Poor-Risk Head and Neck Cancer

Adjuvant Therapy in Patients With Resected Poor-Risk Head and Neck Cancer Authors: Jacques Bernier, Jan B. Vermorken, and Wayne M. Koch Authors Info & Affiliations J Clin Oncol 24, 2629-2635(2006) ...
ascopubs.org

Adjuvant nivolumab in addition to postoperative radiation therapy in locally advanced head and neck cancer: Results of the phase II NadiHN trial.

Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: Updated efficacy and safety data from a randomized phase II trial. This ...
Nasdaq

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients ...

KEYNOTE-689 marks the first positive trial in more than two decades for patients with resected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) Results to be presented at American ...